Exonhit

Quick facts

Phase 2 pipeline

• EHT 0202 etazolate · Neurology
  Etazolate is a phosphodiesterase inhibitor.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Exonhit portfolio CI brief
• Exonhit pipeline updates RSS